Fda
Recent News About Fda
-
The U.S. Food and Drug Administration (FDA) has approved Paxlovid (nirmatrelvir and ritonavir tablets) for treatment of mild-to-moderate COVID-19 in patients who are at highest risk severe illness, according to a release issued May 25.